Patents by Inventor Liyang SHI

Liyang SHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • JAK3 selective inhibitor
    Patent number: 11578060
    Abstract: The present invention relates to a compound of Formula (I)/(II) or pharmaceutically acceptable salts thereof. In Formula (I), Rh, Rg, Rf, m, Re, Rd, Ra, Rb, and Rc are as defined in the description. The present invention further relates to a pharmaceutical composition comprising the compound of Formula (I)/(II) or pharmaceutically acceptable salts thereof, and use of the compound of Formula (I)/(II) or the pharmaceutical composition in the manufacture of a medicament for treating inflammations such as rheumatoid arthritis.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: February 14, 2023
    Assignee: PEKING UNIVERSITY SHENZHEN GRADUATE SCHOOL
    Inventors: Zhengying Pan, Liyang Shi, Xitao Li
  • JAK3 SELECTIVE INHIBITOR
    Publication number: 20210214344
    Abstract: The present invention relates to a compound of Formula (I)/(II) or pharmaceutically acceptable salts thereof. In Formula (I), Rh, Rg, Rf, m, Re, Rd, Ra, Rb, and Rc are as defined in the description. The present invention further relates to a pharmaceutical composition comprising the compound of Formula (I)/(II) or pharmaceutically acceptable salts thereof, and use of the compound of Formula (I)/(II) or the pharmaceutical composition in the manufacture of a medicament for treating inflammations such as rheumatoid arthritis.
    Type: Application
    Filed: May 30, 2019
    Publication date: July 15, 2021
    Inventors: Zhengying PAN, Liyang SHI, Xitao LI